• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD.晚期慢性肾脏病常见症状管理策略的叙述性综述
Kidney Int Rep. 2021 Feb 10;6(4):894-904. doi: 10.1016/j.ekir.2021.01.038. eCollection 2021 Apr.
2
Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis.症状负担和慢性肾脏病患者的健康相关生活质量:全球系统评价和荟萃分析。
PLoS Med. 2022 Apr 6;19(4):e1003954. doi: 10.1371/journal.pmed.1003954. eCollection 2022 Apr.
3
Telephone interventions for symptom management in adults with cancer.针对成年癌症患者症状管理的电话干预措施。
Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2.
4
A systematic review of symptoms experienced by children and young people with kidney failure.儿童和青少年肾衰竭患者的症状系统评价。
Pediatr Nephrol. 2025 Jan;40(1):53-68. doi: 10.1007/s00467-024-06465-8. Epub 2024 Aug 3.
5
6
Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy.针对慢性肾脏病和透析治疗患者瘙痒相关不良症状群的新方法。
Curr Opin Nephrol Hypertens. 2022 Jan 1;31(1):63-71. doi: 10.1097/MNH.0000000000000752.
7
Exploring the Evidence: Symptom Burden in Chronic Kidney Disease.探索证据:慢性肾脏病的症状负担。
Nephrol Nurs J. 2022 May-Jun;49(3):227-255.
8
Symptom burden in chronic kidney disease: a review of recent literature.慢性肾脏病的症状负担:近期文献综述
J Ren Care. 2013 Sep;39(3):140-50. doi: 10.1111/j.1755-6686.2013.12022.x. Epub 2013 Jul 4.
9
Canadian Senior Renal Leaders Community of Practice: Vulnerable Populations With Chronic Kidney Disease-Evidence to Inform Policy.加拿大老年肾脏科专家实践社区:慢性肾脏病脆弱人群——为政策提供信息的证据
Can J Kidney Health Dis. 2020 Jul 24;7:2054358120930977. doi: 10.1177/2054358120930977. eCollection 2020.
10
Conservative Care of the Elderly CKD Patient: A Practical Guide.老年慢性肾脏病患者的保守治疗:实用指南
Adv Chronic Kidney Dis. 2016 Jan;23(1):51-6. doi: 10.1053/j.ackd.2015.08.003.

引用本文的文献

1
Efficacy and safety of HSK21542 for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial.HSK21542用于血液透析患者瘙痒管理的疗效和安全性:一项多中心、随机、双盲、安慰剂对照试验。
Front Pharmacol. 2025 Jun 24;16:1583515. doi: 10.3389/fphar.2025.1583515. eCollection 2025.
2
Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemia.在慢性肾脏病相关性贫血中,尿毒症毒素水平与miR-223相关。
Noncoding RNA Res. 2025 May 2;13:121-130. doi: 10.1016/j.ncrna.2025.04.009. eCollection 2025 Aug.
3
Self-Reported Burden and Health-Related Quality of Life in Acute Kidney Injury Survivors Compared with Patients with Advanced CKD.急性肾损伤幸存者与晚期慢性肾脏病患者自我报告的负担及健康相关生活质量比较
Kidney360. 2025 May 1;6(5):720-727. doi: 10.34067/KID.0000000707. Epub 2025 Jan 17.
4
Hemodialysis Patients' Emotional Profiles and Associated Symptomatology: A Cross-Sectional Multicenter Study.血液透析患者的情绪特征及相关症状学:一项横断面多中心研究。
Nurs Rep. 2025 Apr 30;15(5):152. doi: 10.3390/nursrep15050152.
5
eHealth Solutions for Symptom Assessment and Monitoring in Adults With Chronic Kidney Disease: A Systematic Review.慢性肾脏病成人患者症状评估与监测的电子健康解决方案:一项系统综述
J Clin Nurs. 2025 Sep;34(9):3560-3591. doi: 10.1111/jocn.17827. Epub 2025 May 14.
6
Identification of potential anti aging drugs and targets in chronic kidney disease.慢性肾脏病中潜在抗衰老药物和靶点的鉴定
Sci Rep. 2025 May 3;15(1):15545. doi: 10.1038/s41598-025-96985-6.
7
Electroacupuncture versus sham for insomnia in patients undergoing maintenance hemodialysis: study protocol for a pilot randomized controlled trial.电针与假针刺治疗维持性血液透析患者失眠的疗效比较:一项试点随机对照试验的研究方案
Ann Med. 2025 Dec;57(1):2496410. doi: 10.1080/07853890.2025.2496410. Epub 2025 Apr 29.
8
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.为临床实践指南界定糖尿病、肥胖症、心血管疾病及慢性肾脏病患者报告的结局——指南研讨会特别工作组的观点
Cardiovasc Diabetol. 2025 Feb 7;24(1):68. doi: 10.1186/s12933-024-02550-2.
9
Comprehensive geriatric assessment of older patients with renal disease: a cross-sectional survey.老年肾脏病患者的综合老年评估:一项横断面调查。
Sci Rep. 2024 Apr 16;14(1):8758. doi: 10.1038/s41598-024-59370-3.
10
Holistic care and symptom management for pediatric kidney transplant recipients.儿科肾移植受者的整体护理和症状管理。
Pediatr Nephrol. 2024 Jun;39(6):1759-1769. doi: 10.1007/s00467-023-06175-7. Epub 2023 Oct 18.

本文引用的文献

1
US Trends in Prevalence of Sleep Problems and Associations with Chronic Kidney Disease and Mortality.美国睡眠问题的流行趋势及与慢性肾脏病和死亡率的关系。
Kidney360. 2020 May 1;1(6):458-468. doi: 10.34067/KID.0000862019. eCollection 2020 Jun 25.
2
Symptom-burden in people living with frailty and chronic kidney disease.虚弱和慢性肾脏病患者的症状负担。
BMC Nephrol. 2020 Sep 23;21(1):411. doi: 10.1186/s12882-020-02063-6.
3
CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management.慢性肾脏病相关性瘙痒:诊断、发病机制及管理的新见解
Kidney Int Rep. 2020 May 8;5(9):1387-1402. doi: 10.1016/j.ekir.2020.04.027. eCollection 2020 Sep.
4
Health-related quality of life, functional impairment and comorbidity in people with mild-to-moderate chronic kidney disease: a cross-sectional study.轻度至中度慢性肾脏病患者的健康相关生活质量、功能障碍及合并症:一项横断面研究。
BMJ Open. 2020 Aug 6;10(8):e040286. doi: 10.1136/bmjopen-2020-040286.
5
Multiple Dimensions and Correlates of Fatigue in Individuals on Hemodialysis.血液透析患者疲劳的多维度特征及其相关因素
Nephrol Nurs J. 2020 May-Jun;47(3):215-251.
6
Effects of Foot Massage on Severity of Fatigue and Quality of Life in Hemodialysis Patients: A Randomized Controlled Trial.足部按摩对血液透析患者疲劳严重程度及生活质量的影响:一项随机对照试验
Int J Community Based Nurs Midwifery. 2020 Apr;8(2):92-102. doi: 10.30476/IJCBNM.2020.81662.0.
7
Kidney Supportive Care: Core Curriculum 2020.肾脏支持性护理:2020 年核心课程。
Am J Kidney Dis. 2020 May;75(5):793-806. doi: 10.1053/j.ajkd.2019.10.016. Epub 2020 Mar 12.
8
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.一项针对血液透析瘙痒患者的非那雄胺的 3 期临床试验。
N Engl J Med. 2020 Jan 16;382(3):222-232. doi: 10.1056/NEJMoa1912770. Epub 2019 Nov 8.
9
Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.慢性肾脏病相关认知障碍:发病机制、管理和预防。
Am J Kidney Dis. 2019 Dec;74(6):782-790. doi: 10.1053/j.ajkd.2019.05.017. Epub 2019 Aug 1.
10
Reasons for Underreporting of Uremic Pruritus in People With Chronic Kidney Disease: A Qualitative Study.慢性肾脏病患者尿毒症瘙痒漏报的原因:一项定性研究。
J Pain Symptom Manage. 2019 Oct;58(4):578-586.e2. doi: 10.1016/j.jpainsymman.2019.06.010. Epub 2019 Jun 19.

晚期慢性肾脏病常见症状管理策略的叙述性综述

A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD.

作者信息

Metzger Maureen, Abdel-Rahman Emaad M, Boykin Heather, Song Mi-Kyung

机构信息

University of Virginia School of Nursing, Charlottesville, Virginia, USA.

Division of Nephrology, Nephrology, University of Virginia, Charlottesville, Virginia, USA.

出版信息

Kidney Int Rep. 2021 Feb 10;6(4):894-904. doi: 10.1016/j.ekir.2021.01.038. eCollection 2021 Apr.

DOI:10.1016/j.ekir.2021.01.038
PMID:33912741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8071652/
Abstract

Patients with advanced chronic kidney disease (CKD) experience multiple bothersome symptoms, undermining their quality of life (QOL). With growing attention to the importance of symptom management in advanced CKD, the evidence regarding symptoms is increasing. In this review, we briefly summarize the current evidence of effective pharmacologic and nonpharmacologic interventions to improve symptoms and QOL in patients with advanced CKD, including those on dialysis. We focused on symptoms that are commonly experienced by patients, such as pain, fatigue, sleep disturbances, itching, nausea and vomiting, cognitive impairment, and anxiety and depression. We noted that research in symptom science focused on improving symptom management in CKD is still very limited. In addition to the lack of clinical practice guidelines to address those common symptoms, the major gaps in the current literature include the evidence regarding mechanistic pathways to inform the development of effective symptom management for CKD populations, the evidence to confirm effective pharmacologic interventions in other populations for CKD populations, and research on how to incorporate effective symptom management approaches into clinical care. Although improving mortality remains as an important area in the kidney community, there is an urgent need to focus on improving symptom management to improve QOL in advanced CKD.

摘要

晚期慢性肾脏病(CKD)患者会经历多种令人困扰的症状,这会损害他们的生活质量(QOL)。随着对晚期CKD症状管理重要性的日益关注,有关症状的证据也在增加。在本综述中,我们简要总结了当前关于有效药物和非药物干预措施的证据,这些措施旨在改善晚期CKD患者(包括接受透析的患者)的症状和生活质量。我们关注的是患者常见的症状,如疼痛、疲劳、睡眠障碍、瘙痒、恶心和呕吐、认知障碍以及焦虑和抑郁。我们注意到,针对改善CKD症状管理的症状科学研究仍然非常有限。除了缺乏针对这些常见症状的临床实践指南外,当前文献中的主要差距包括关于为CKD人群制定有效症状管理方法提供信息的机制途径的证据、在其他人群中确认对CKD人群有效的药物干预措施的证据,以及关于如何将有效症状管理方法纳入临床护理的研究。尽管提高死亡率仍然是肾脏领域的一个重要方面,但迫切需要关注改善症状管理以提高晚期CKD患者的生活质量。